IL6 and Sepsis: Inflammatory biomarkers, such as interleukin-6 (IL-6), neutrophil gelatinase-associated lipocalin (NGAL), and high-mobility group box 1 (HMGB1), have been effective at differentiating sepsis, predicting prognosis, and monitoring treatment in patients in the ICU.